1 Introduction to Research & Analysis Reports
1.1 Gastric Antisecretory Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Antisecretory Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Antisecretory Drug Overall Market Size
2.1 Global Gastric Antisecretory Drug Market Size: 2022 VS 2029
2.2 Global Gastric Antisecretory Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastric Antisecretory Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Gastric Antisecretory Drug Players in Global Market
3.2 Top Global Gastric Antisecretory Drug Companies Ranked by Revenue
3.3 Global Gastric Antisecretory Drug Revenue by Companies
3.4 Global Gastric Antisecretory Drug Sales by Companies
3.5 Global Gastric Antisecretory Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastric Antisecretory Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastric Antisecretory Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Antisecretory Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastric Antisecretory Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Antisecretory Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gastric Antisecretory Drug Market Size Markets, 2022 & 2029
4.1.2 H2-receptor Antagonists
4.1.3 Gastric Proton Pump Inhibitors
4.1.4 Others
4.2 By Type – Global Gastric Antisecretory Drug Revenue & Forecasts
4.2.1 By Type – Global Gastric Antisecretory Drug Revenue, 2018-2023
4.2.2 By Type – Global Gastric Antisecretory Drug Revenue, 2024-2029
4.2.3 By Type – Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Gastric Antisecretory Drug Sales & Forecasts
4.3.1 By Type – Global Gastric Antisecretory Drug Sales, 2018-2023
4.3.2 By Type – Global Gastric Antisecretory Drug Sales, 2024-2029
4.3.3 By Type – Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
4.4 By Type – Global Gastric Antisecretory Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gastric Antisecretory Drug Market Size, 2022 & 2029
5.1.2 Dyspepsia
5.1.3 Peptic Ulcer
5.1.4 Gastroesophageal Reflux
5.1.5 Others
5.2 By Application – Global Gastric Antisecretory Drug Revenue & Forecasts
5.2.1 By Application – Global Gastric Antisecretory Drug Revenue, 2018-2023
5.2.2 By Application – Global Gastric Antisecretory Drug Revenue, 2024-2029
5.2.3 By Application – Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Gastric Antisecretory Drug Sales & Forecasts
5.3.1 By Application – Global Gastric Antisecretory Drug Sales, 2018-2023
5.3.2 By Application – Global Gastric Antisecretory Drug Sales, 2024-2029
5.3.3 By Application – Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
5.4 By Application – Global Gastric Antisecretory Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gastric Antisecretory Drug Market Size, 2022 & 2029
6.2 By Region – Global Gastric Antisecretory Drug Revenue & Forecasts
6.2.1 By Region – Global Gastric Antisecretory Drug Revenue, 2018-2023
6.2.2 By Region – Global Gastric Antisecretory Drug Revenue, 2024-2029
6.2.3 By Region – Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Gastric Antisecretory Drug Sales & Forecasts
6.3.1 By Region – Global Gastric Antisecretory Drug Sales, 2018-2023
6.3.2 By Region – Global Gastric Antisecretory Drug Sales, 2024-2029
6.3.3 By Region – Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gastric Antisecretory Drug Revenue, 2018-2029
6.4.2 By Country – North America Gastric Antisecretory Drug Sales, 2018-2029
6.4.3 US Gastric Antisecretory Drug Market Size, 2018-2029
6.4.4 Canada Gastric Antisecretory Drug Market Size, 2018-2029
6.4.5 Mexico Gastric Antisecretory Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gastric Antisecretory Drug Revenue, 2018-2029
6.5.2 By Country – Europe Gastric Antisecretory Drug Sales, 2018-2029
6.5.3 Germany Gastric Antisecretory Drug Market Size, 2018-2029
6.5.4 France Gastric Antisecretory Drug Market Size, 2018-2029
6.5.5 U.K. Gastric Antisecretory Drug Market Size, 2018-2029
6.5.6 Italy Gastric Antisecretory Drug Market Size, 2018-2029
6.5.7 Russia Gastric Antisecretory Drug Market Size, 2018-2029
6.5.8 Nordic Countries Gastric Antisecretory Drug Market Size, 2018-2029
6.5.9 Benelux Gastric Antisecretory Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gastric Antisecretory Drug Revenue, 2018-2029
6.6.2 By Region – Asia Gastric Antisecretory Drug Sales, 2018-2029
6.6.3 China Gastric Antisecretory Drug Market Size, 2018-2029
6.6.4 Japan Gastric Antisecretory Drug Market Size, 2018-2029
6.6.5 South Korea Gastric Antisecretory Drug Market Size, 2018-2029
6.6.6 Southeast Asia Gastric Antisecretory Drug Market Size, 2018-2029
6.6.7 India Gastric Antisecretory Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gastric Antisecretory Drug Revenue, 2018-2029
6.7.2 By Country – South America Gastric Antisecretory Drug Sales, 2018-2029
6.7.3 Brazil Gastric Antisecretory Drug Market Size, 2018-2029
6.7.4 Argentina Gastric Antisecretory Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gastric Antisecretory Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gastric Antisecretory Drug Sales, 2018-2029
6.8.3 Turkey Gastric Antisecretory Drug Market Size, 2018-2029
6.8.4 Israel Gastric Antisecretory Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Gastric Antisecretory Drug Market Size, 2018-2029
6.8.6 UAE Gastric Antisecretory Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Gastric Antisecretory Drug Major Product Offerings
7.1.4 Bayer Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Company Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Major Product Offerings
7.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.2.5 Cadila Pharmaceuticals Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Gastric Antisecretory Drug Major Product Offerings
7.3.4 AstraZeneca Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Jiangsu Aosaikang
7.4.1 Jiangsu Aosaikang Company Summary
7.4.2 Jiangsu Aosaikang Business Overview
7.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Major Product Offerings
7.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.4.5 Jiangsu Aosaikang Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Gastric Antisecretory Drug Major Product Offerings
7.5.4 Eisai Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastric Antisecretory Drug Major Product Offerings
7.6.4 Pfizer Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Altana Pharma
7.7.1 Altana Pharma Company Summary
7.7.2 Altana Pharma Business Overview
7.7.3 Altana Pharma Gastric Antisecretory Drug Major Product Offerings
7.7.4 Altana Pharma Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.7.5 Altana Pharma Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Gastric Antisecretory Drug Major Product Offerings
7.8.4 Takeda Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 NCPC
7.9.1 NCPC Company Summary
7.9.2 NCPC Business Overview
7.9.3 NCPC Gastric Antisecretory Drug Major Product Offerings
7.9.4 NCPC Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.9.5 NCPC Key News & Latest Developments
7.10 Luoxin
7.10.1 Luoxin Company Summary
7.10.2 Luoxin Business Overview
7.10.3 Luoxin Gastric Antisecretory Drug Major Product Offerings
7.10.4 Luoxin Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.10.5 Luoxin Key News & Latest Developments
8 Global Gastric Antisecretory Drug Production Capacity, Analysis
8.1 Global Gastric Antisecretory Drug Production Capacity, 2018-2029
8.2 Gastric Antisecretory Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Antisecretory Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Antisecretory Drug Supply Chain Analysis
10.1 Gastric Antisecretory Drug Industry Value Chain
10.2 Gastric Antisecretory Drug Upstream Market
10.3 Gastric Antisecretory Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Antisecretory Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の胃酸分泌抑薬市場予測2023-2029：H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他 |
| 【英語タイトル】Gastric Antisecretory Drug Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5577 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：74 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の胃酸分泌抑薬市場規模と予測を収録しています。・世界の胃酸分泌抑薬市場：売上、2018年-2023年、2024年-2029年 ・世界の胃酸分泌抑薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の胃酸分泌抑薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「H2受容体拮抗薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 胃酸分泌抑薬のグローバル主要企業は、Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxinなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、胃酸分泌抑薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の胃酸分泌抑薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の胃酸分泌抑薬市場：タイプ別市場シェア、2022年 ・H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他 世界の胃酸分泌抑薬市場：用途別、2018年-2023年、2024年-2029年 世界の胃酸分泌抑薬市場：用途別市場シェア、2022年 ・消化不良、消化性潰瘍、胃食道逆流症、その他 世界の胃酸分泌抑薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の胃酸分泌抑薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における胃酸分泌抑薬のグローバル売上、2018年-2023年 ・主要企業における胃酸分泌抑薬のグローバル売上シェア、2022年 ・主要企業における胃酸分泌抑薬のグローバル販売量、2018年-2023年 ・主要企業における胃酸分泌抑薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxin ************************************************************* ・調査・分析レポートの概要 胃酸分泌抑薬市場の定義 市場セグメント 世界の胃酸分泌抑薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の胃酸分泌抑薬市場規模 世界の胃酸分泌抑薬市場規模：2022年 VS 2029年 世界の胃酸分泌抑薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの胃酸分泌抑薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の胃酸分泌抑薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他 胃酸分泌抑薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：消化不良、消化性潰瘍、胃食道逆流症、その他 胃酸分泌抑薬の用途別グローバル売上・予測 ・地域別市場分析 地域別胃酸分泌抑薬市場規模 2022年と2029年 地域別胃酸分泌抑薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxin ... |
Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.
This report aims to provide a comprehensive presentation of the global market for Gastric Antisecretory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Antisecretory Drug. This report contains market size and forecasts of Gastric Antisecretory Drug in global, including the following market information:
Global Gastric Antisecretory Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastric Antisecretory Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gastric Antisecretory Drug companies in 2022 (%)
The global Gastric Antisecretory Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
H2-receptor Antagonists Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastric Antisecretory Drug include Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda and NCPC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastric Antisecretory Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Antisecretory Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Type, 2022 (%)
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others
Global Gastric Antisecretory Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Application, 2022 (%)
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others
Global Gastric Antisecretory Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Antisecretory Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastric Antisecretory Drug revenues share in global market, 2022 (%)
Key companies Gastric Antisecretory Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastric Antisecretory Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastric Antisecretory Drug, market overview.
Chapter 2: Global Gastric Antisecretory Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Gastric Antisecretory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastric Antisecretory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastric Antisecretory Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の胃酸分泌抑薬市場予測2023-2029：H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他] (コード：MMG23JU5577)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の胃酸分泌抑薬市場予測2023-2029：H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他]についてメールでお問い合わせ |
